Fagron
18.86
04-4月-25 11:17:00
15 分の遅延
株式
-0.40
-2.08%
本日の幅
18.74 - 19.22
ISIN
BE0003874915
ソース
Cboe
-
Fagron publishes its annual report 2024
06 3 2025 01:00:00 提供 Nasdaq GlobeNewswire
-
20 2 2025 01:00:00 提供 Nasdaq GlobeNewswire
-
Fagron solidifies its leadership position with the acquisition of Guinama in Spain
04 2 2025 01:00:00 提供 Nasdaq GlobeNewswire
-
07 1 2025 01:00:00 提供 Nasdaq GlobeNewswire
-
Fagron updates on FDA communication regarding the June 2024 inspection at Wichita
23 12 2024 01:00:00 提供 Nasdaq GlobeNewswire
-
Disclosure of notification received from FMR LLC
26 11 2024 12:59:27 提供 Nasdaq GlobeNewswire
-
10 10 2024 01:00:00 提供 Nasdaq GlobeNewswire
-
Disclosure of notification received from AOC Pharma S.à r.l.
08 10 2024 16:00:00 提供 Nasdaq GlobeNewswire
-
Fagron completes share buy-back program
13 9 2024 12:28:48 提供 Nasdaq GlobeNewswire
-
Fagron’s share buy-back program: Weekly update
06 9 2024 12:24:46 提供 Nasdaq GlobeNewswire
-
Fagron’s share buy-back program: Weekly update
30 8 2024 12:34:33 提供 Nasdaq GlobeNewswire
-
Fagron’s share buy-back program: Weekly update
23 8 2024 12:44:55 提供 Nasdaq GlobeNewswire
-
01 8 2024 01:00:00 提供 Nasdaq GlobeNewswire
-
Fagron shareholders approve all voting items at AGM and EGM
13 5 2024 13:00:00 提供 Nasdaq GlobeNewswire
-
Fagron publishes agenda for 2024 annual shareholders meeting and extraordinary general meeting
12 4 2024 02:00:00 提供 Nasdaq GlobeNewswire
-
Record revenue of €209 million in first quarter reflecting 15% topline growth
11 4 2024 01:00:00 提供 Nasdaq GlobeNewswire
-
Disclosure notification from Mawer Investment Management Ltd.
19 3 2024 13:00:00 提供 Nasdaq GlobeNewswire
-
Fagron publishes annual report 2023
14 3 2024 13:30:00 提供 Nasdaq GlobeNewswire
-
Fagron delivers strong performance with 12% topline growth and 14% increase in REBITDA for FY 2023
15 2 2024 01:00:00 提供 Nasdaq GlobeNewswire
-
Disclosure notification from AOC Pharma S.à r.l. – passing 10% threshold
08 1 2024 02:00:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >